Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
An update from Mayne Pharma Group ( (AU:MYX) ) is now available.
State Street Corporation, through its subsidiaries such as State Street Global Advisors and State Street Bank and Trust Company, has become a substantial holder in Mayne Pharma Group Limited. This development indicates a significant investment and interest in Mayne Pharma, potentially impacting the company’s market position and signaling confidence in its future prospects.
More about Mayne Pharma Group
YTD Price Performance: 52.78%
Average Trading Volume: 2,128
Technical Sentiment Signal: Sell
Current Market Cap: $369.5M
Learn more about MYX stock on TipRanks’ Stock Analysis page.